The No Surprises Act, a landmark federal law intended to shield patients from unexpected medical bills, is facing scrutiny as some allege it’s being exploited for profit. A recent investigation reveals a Texas-based couple, Scott and Alla LaRocque, have built a business – HaloMD – that critics say is capitalizing on the law’s dispute resolution process, potentially undermining its original intent. This situation highlights the complexities of implementing broad healthcare legislation and the potential for unintended consequences, raising questions about the future of the No Surprises Act and patient protections.
Enacted in 2022, the No Surprises Act was designed to protect individuals insured through private plans and those without insurance from “balance billing” – the practice where providers charge patients the difference between their negotiated rate with insurers and the actual cost of care, particularly in emergency situations or when patients unknowingly receive care from out-of-network providers. The law established an independent dispute resolution (IDR) process to settle disagreements between providers and insurers, aiming to provide a fair and transparent system. However, the investigation suggests that HaloMD is strategically navigating this IDR process to secure substantial payments, raising concerns about fairness and the law’s effectiveness.
How HaloMD Operates Within the No Surprises Act
Scott LaRocque, a physician, and Alla LaRocque founded MpowerHealth, the parent company of HaloMD. The company essentially acts as a representative for out-of-network providers, submitting claims to insurers and initiating the IDR process when disputes arise. According to the STAT+ investigation, HaloMD’s strategy involves submitting claims for relatively low-cost services, often telehealth consultations, and then aggressively pursuing higher payments through the IDR process. This approach allows them to avoid the more complex and potentially lower-paying disputes associated with major medical procedures.
Critics argue that HaloMD is exploiting a loophole in the IDR process. The law allows for consideration of the 80th percentile of billed charges in a geographic area when determining a fair payment. HaloMD reportedly inflates its billed charges to position itself favorably in this calculation, effectively increasing the potential payout. The company then takes a significant percentage of the awarded amount as its fee, generating substantial profits.
Concerns Raised by Insurers and Experts
Insurance companies are voicing strong objections to HaloMD’s practices. They contend that the company is driving up healthcare costs and undermining the intent of the No Surprises Act. Insurers argue that the IDR process is being flooded with claims from HaloMD, diverting resources and delaying resolutions for legitimate disputes. They also express concern that the inflated billed charges used by HaloMD are distorting the market and creating an unsustainable system.
“We are seeing a pattern of behavior that is clearly designed to game the system,” said a spokesperson for America’s Health Insurance Plans (AHIP), as reported by STAT+. “This is not about protecting patients; it’s about enriching a few companies at the expense of everyone else.”
The Role of Arbitration and Medicare Advantage
The IDR process relies on certified independent dispute resolution entities to make final decisions on payment amounts. The investigation highlights concerns about the consistency and fairness of these decisions, as well as the potential for bias. The issue is particularly acute within Medicare Advantage plans, where default enrollment can leave beneficiaries unaware they are receiving care from out-of-network providers, making them vulnerable to balance billing and reliant on the IDR process.
The Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) are aware of the concerns surrounding HaloMD and the IDR process. CMS has issued guidance clarifying its interpretation of the No Surprises Act and has indicated This proves monitoring the situation closely. However, critics argue that more robust enforcement and potential legislative changes are needed to address the loopholes and prevent further exploitation.
What’s Next for the No Surprises Act?
The future of the No Surprises Act remains uncertain. Ongoing litigation challenging various aspects of the law could impact its implementation and effectiveness. The Biden administration has signaled its commitment to protecting patients from surprise medical bills, but the challenges posed by companies like HaloMD demonstrate the demand for continued vigilance and proactive measures.
Currently, CMS is reviewing the IDR process and considering potential modifications to address concerns about fairness and transparency. A key focus is likely to be on clarifying the criteria for determining reasonable payment amounts and strengthening oversight of dispute resolution entities. The agency is expected to issue further guidance in the coming months, outlining its plans for addressing these issues. The next significant checkpoint is expected in late summer 2026, when CMS is scheduled to release updated data on IDR outcomes and proposed regulatory changes.
This situation serves as a crucial reminder that even well-intentioned legislation can be susceptible to unintended consequences. Protecting patients from surprise medical bills requires not only strong laws but also diligent oversight and a commitment to ensuring that the system operates fairly for all stakeholders. The ongoing debate surrounding HaloMD and the No Surprises Act underscores the importance of continued scrutiny and adaptation to safeguard patient interests in a complex healthcare landscape.
Have thoughts on the No Surprises Act and its implementation? Share your experiences and perspectives in the comments below. And please, share this article with anyone who might benefit from understanding these important healthcare issues.
